Solving ‘Vein-to-Vein’ Cell & Gene Therapy Supply Chain Challenges
The world’s COVID-19 vaccine distribution has shown the strengths and weaknesses of today’s supply chains. Healthcare companies pioneering cell and gene therapies—which rely on human cellular material—need to pay particular attention to lessons learned as they face unique supply chain challenges of their own. It all starts with planning.
Supply Chain’s Next Big Challenge: Saving Lives and Businesses
Supply chains are helping distribute life-saving vaccines, but they’re also needed to help get the economy back to normal. We need to do both, but it won’t be easy.
COVID-19 Vaccine Distribution: How Agile Supply Chain Management Can Save Lives
As major pharma players—including Pfizer, J&J, Gilead, Moderna and AstraZeneca—announce vaccines for the COVID-19 virus that’s claimed over 1.3 million lives, life sciences companies have an increased focus on delivering their vaccines to millions—potentially billions—of people.
Pandemic Productivity: Fixing Healthcare Providers’ Work-from-Home Revenue Losses
At the center of the COVID-19 storm, most healthcare providers generally did an exemplary job transitioning operations from on-premises to work-from-home. But that may have been the easy part.
Healthcare Supply Chains: Fixing Weak Links & Emerging Stronger Post-COVID-19
Supply chain expert Ron Rod details how healthcare providers, payers and life sciences companies are responding to COVID-19 supply chain interruptions while preparing to emerge stronger in the future.
Upcoming Events
Meet and greet us at an upcoming event!